Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: Conceptual framework and example-Reference-Cited by-同舟云学术

Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: Conceptual framework and example

Published:2013-08-19 Issue:2 Volume:10 Page:152-161
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Leoutsakos Jeannie‐Marie S.¹,Bartlett Alexandra L.²,Forrester Sarah N.¹,Lyketsos Constantine G.¹

Affiliation:

1. Department of Psychiatry, Division of Geriatric Psychiatry and NeuropsychiatryJohns Hopkins University School of MedicineBaltimoreMDUSA

2. STEM Magnet ProgramSouth River High SchoolEdgewaterMDUSA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2013.05.1776

Reference51 articles.

1. Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible

2. Annual Rate and Predictors of Conversion to Dementia in Subjects Presenting Mild Cognitive Impairment Criteria Defined according to a Population-Based Study

3. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. Mild cognitive impairment in a community sample: The Sydney Memory and Ageing Study

5. Four-year outcome of mild cognitive impairment: The contribution of executive dysfunction.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Big Data Analytical Approaches to the NACC Dataset;Alzheimer Disease & Associated Disorders;2018-01

2. Randomized Deep Learning Methods for Clinical Trial Enrichment and Design in Alzheimer's Disease;Deep Learning for Medical Image Analysis;2017

3. Five‐year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2015-11-14

4. Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials;PLOS ONE;2015-09-17

5. Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia;Journal of Alzheimer's Disease;2015-09-09